Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 16/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 15/20 | 0.59 |
| ▸ | MEN1 | O00255 | 14/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 10/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.59 |
| ▸ | HTT | P42858 | 4/20 | 0.59 |
| ▸ | HPGD | P15428 | 4/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | LMNA | P02545 | 7/20 | 0.57 |
| ▸ | GAA | P10253 | 11/20 | 0.56 |
| ▸ | RAB9A | P51151 | 10/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.55 |
| ▸ | ALPI | P09923 | 1/20 | 0.55 |
| ▸ | ALPG | P10696 | 1/20 | 0.55 |
| ▸ | NPC1 | O15118 | 9/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30714871 | 1.00 | MAPT (0.59) | MAPTKMT2AMEN1SMN1; SMN2KDM4E | |
| SCHEMBL1164673 | 0.81 | MBD2 (0.65) | MAPTKMT2AMEN1SMN1; SMN2KDM4E | |
| SCHEMBL1164671 | 0.81 | MBD2 (0.65) | MAPTKMT2AMEN1SMN1; SMN2KDM4E | |
| SCHEMBL15494570 | 0.78 | MAPT (0.61) | MAPTKMT2AMEN1SMN1; SMN2KDM4E | |
| SCHEMBL13779288 | 0.78 | MAPT (0.75) | MAPTKMT2AMEN1SMN1; SMN2KDM4E | |
| SCHEMBL15965635 | 0.77 | MAPT (0.60) | MAPTKMT2AMEN1SMN1; SMN2KDM4E | |
| SCHEMBL19437097 | 0.76 | MAPT (0.58) | MAPTKMT2AMEN1SMN1; SMN2KDM4E | |
| SCHEMBL1165591 | 0.76 | MAPT (0.68) | MAPTKMT2AMEN1SMN1; SMN2KDM4E | |
| SCHEMBL1165592 | 0.76 | MAPT (0.68) | MAPTKMT2AMEN1SMN1; SMN2KDM4E | |
| SCHEMBL1132582 | 0.75 | MAPT (0.58) | MAPTKMT2AMEN1SMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4401726-A1 | PROCESSES OF PREPARING PSILOCIN AND PSILOCYBIN | Terran Biosciences Inc. (US) | 2024-07-24 | — | — | EP | claimed |
| WO-2023250423-A1 | ELECTROLYZER HAVING AN ANODE-SIDE CATALYST AND RELATED METHODS | GEORGIA TECH RESEARCH CORPORATION (US) | 2023-12-28 | — | — | WO | claimed |
| EP-4189359-A1 | DEVICE FOR TESTING OF AN ENVIRONMENTAL SAMPLE | Becton, Dickinson and Company (US) | 2023-06-07 | — | — | EP | claimed |
| WO-2023043794-A1 | PROCESSES OF PREPARING PSILOCIN AND PSILOCYBIN | TERRAN BIOSCIENCES INC. (US) | 2023-03-23 | — | — | WO | claimed |
| WO-2022056084-A1 | DEVICE FOR TESTING OF AN ENVIRONMENTAL SAMPLE | BECTON, DICKINSON AND COMPANY (US) | 2022-03-17 | — | — | WO | claimed |
| EP-4746964-A1 | NEW PYRAZOLOPYRIDINE DERIVATIVES | F. Hoffmann-La Roche AG (CH) | 2026-05-27 | — | — | EP | disclosed |
| EP-4746965-A1 | BENZIMIDAZOLES AS SIK-ACTIVITY MODULATORS | F. Hoffmann-La Roche AG (CH) | 2026-05-27 | — | — | EP | disclosed |
| EP-4704830-A2 | MRGPRX2 INHIBITORS AND METHODS OF USE THEREOF | Septerna, Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| EP-4698531-A1 | PYRROLOPYRAZINE COMPOUNDS, PREPARATION THEREOF AND THERAPEUTIC USES THEREOF | Sanofi (FR) | 2026-02-25 | — | — | EP | disclosed |
| EP-4043922-B1 | METHOD FOR THE CLASSIFICATION, DISCRIMINATION AND IDENTIFICATION OF AN ABT OR BALLISTIC THREAT FROM A RADAR SIGNAL | Mbda italia spa (IT) | 2025-10-08 | — | — | EP | disclosed |
| EP-3252068-B1 | METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION USING OLIGONUCLEOTIDE BASED DRUGS ADMINISTERED IN VIVO OR IN VITRO | SMITH LARRY J (US) | 2025-07-02 | — | — | EP | disclosed |
| US-12319914-B2 | Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro | SMITH LARRY J (US) | 2025-06-03 | — | — | US | disclosed |
| US-11359201-B2 | Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro | SMITH LARRY J (US) | 2022-06-14 | — | — | US | disclosed |
| WO-2022118210-A1 | SUBSTITUTED THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS | IDEAYA BIOSCIENCES, INC. (US) | 2022-06-09 | — | — | WO | disclosed |
| WO-2022109721-A1 | NON AGGREGATING MICROFLUIDIC MIXER AND METHODS THEREFOR | Precision Nanosystems Inc. (CA) | 2022-06-02 | — | — | WO | disclosed |
| US-20220160812-A1 | A PHARMACEUTICALLY ACTIVE SUBSTANCE | CYTOGENESIS LTD. (GB) | 2022-05-26 | — | — | US | disclosed |
| US-20220162552-A1 | Nonviral Modification of T Cell Gene Expression | Precision Nanosystems Inc. (CA) | 2022-05-26 | — | — | US | disclosed |
| WO-2022084280-A1 | SUBSTITUTED 6,7-DIHYDRO-5H-BENZO[7]ANNULENE COMPOUNDS AND THEIR DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF | SANOFI (FR) | 2022-04-28 | — | — | WO | disclosed |
| CN-109790191-B | Platinum complexes and methods of use thereof | 香港大学 | 2022-04-08 | — | — | CN | disclosed |
| EP-3972626-A1 | A PHARMACEUTICALLY ACTIVE SUBSTANCE | Cytopharma GmbH (DE) | 2022-03-30 | — | — | EP | disclosed |